R. Andrew Ramelmeier
2021
Compensation breakdown
Bonus | $50,000 |
---|---|
Non-Equity Incentive Plan | $179,712 |
Option Awards | $591,728 |
Salary | $416,000 |
Stock Awards | $447,600 |
Other | $5,554 |
Total | $1,690,594 |
Ramelmeier received $591.7K in option awards, accounting for 35% of the total pay in 2021.
Ramelmeier also received $50K in bonus, $179.7K in non-equity incentive plan, $416K in salary, $447.6K in stock awards and $5.6K in other compensation.
Rankings
In 2021, R. Andrew Ramelmeier's compensation ranked 6,735th out of 12,415 executives tracked by ExecPay. In other words, Ramelmeier earned more than 45.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,735 | 46th |
Manufacturing | 2,922 | 47th |
Chemicals And Allied Products | 1,288 | 46th |
Drugs | 1,147 | 45th |
Biological Products, Except Diagnostic Substances | 271 | 40th |
Pay ratio
R. Andrew Ramelmeier's Pay | $1,690,594 |
---|---|
Median Employee's Pay | $170,218 |
Pay Ratio | 10to 1 |
In 2021, the annual total compensation of R. Andrew Ramelmeier was $1,690,594.
The annual total compensation of the median employee at Sangamo Biosciences was $170,218.
The ratio of R. Andrew Ramelmeier's pay to the pay of median employee was therefore 10 to one.
Ramelmeier's colleagues
We found five more compensation records of executives who worked with R. Andrew Ramelmeier at Sangamo Biosciences in 2021.
2021
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
2021
Robert Schott
Sangamo Biosciences
Senior Vice President, Head of Development
2021
D McClung
Sangamo Biosciences
Chief Operating Officer
2021
Prathyusha Duraibabu
Sangamo Biosciences
Chief Financial Officer
2021
Sung Lee
Sangamo Biosciences